Browsing Tag
United States
1074 posts
Zip shares jump 16% as US growth drives record A$269m cash earnings
Zip shares jumped 16% after FY26 cash EBTDA rose 58% to A$268.9m, with US growth driving a A$340m FY27 earnings target.
iFOREX (LSE: IFRX) shares plunge after yen shock exposes risk inside its unhedged CFD model
iFOREX shares plunged after a sharp yen move hit its internally managed client exposure, turning a promising H1 recovery into a major test of the CFD broker’s risk model.
Breville (ASX: BRG) shares slide 6% despite record A$1.81bn sales as FY27 tariff uncertainty stays unresolved
Breville hit record A$1.81bn FY26 sales, but EBIT rose just 1.2% and ASX: BRG fell 6% as tariffs and FY27 margin visibility remained uncertain.
Trump pauses 50% Canada tariffs after saying US and Canada reached trade deal
Donald Trump has postponed new 50% tariffs on about $20 billion of Canadian goods for three days after saying the United States and Canada reached a last-minute trade agreement, giving Mark Carney’s government a narrow window to finalize terms.
US sanctions ICC president Tomoko Akane as Trump administration escalates campaign against court
The United States has sanctioned International Criminal Court President Tomoko Akane and senior trial lawyer Abdoulaye Seye, escalating Washington’s confrontation with the Hague tribunal over investigations involving Israel and the United States.
Cochlear (ASX: COH) shares rebound as FY27 guidance tests recovery after historic sell-off
Cochlear profit fell 22%, but stronger second-half sales and A$330m-A$350m FY27 guidance sent ASX: COH higher as investors tested the recovery.
Reliance Worldwide gets A$4.75 Brookfield bid as 95% statutory profit fall puts recovery value in play
Brookfield offers A$4.75 a share for Reliance Worldwide as FY26 profit drops 95%, putting takeover terms and ASX's FY27 margin recovery firmly in focus.
Trump scales back South Korea military drills as Kim Jong Un diplomacy tests US alliance
Trump scales back US-South Korea military drills in a new overture to Kim Jong Un, raising questions about North Korea diplomacy and alliance readiness.
Rentokil (LSE: RTO) shares remain near their post-results low as North America turnaround faces a harder test
Rentokil Initial is generating more profit, cash and margin from North America, but investors erased a fifth of its value after management prioritised revenue recovery over its old 2027 margin target. Two weeks later, the shares have barely recovered.
Mesoblast completes 350-patient Phase 3 treatment as mid-2027 back pain readout becomes next valuation test
Mesoblast has completed treatment of 350 Phase 3 back pain patients, putting rexlemestrocel-L on course for a pivotal mid-2027 efficacy readout.